SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.879+3.4%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bill small who wrote (732)5/10/1996 1:00:00 PM
From: Keiko   of 14328
 
Bill, sorry for my delay in getting back to you.....the faster I go , the behinder
I get.!!!....

I have looked over my past notes as it applies to HIV Serocard and
Salivacard. costs...also spoke with former board member with TRIBY...
Robby Long just might be able to confirm these prices and margins.
or get back to us after consulting with Jonathan O' Connell..

In regards to SEROCARD/SALIVACARD HIV..TRIBY's cost is about
@ 0.62 cents...fully loaded out the door...(ie.,packaging,overhead, etc.)
their latest deals, I believe have been wholesaled at from $ 1.75 to $ 3.25.
an average of $ 2.25 for the latest batch of orders from the Orient.
Margins of about $ 1.75....???

I'm told the new UNIGOLD HIV will probably come in less expensive
to manufacture, principally due to lack of other reagents and
their costs of antigen.!!

The important feature is that Trinity has lots of "room to manuvuer",
in the face of any future contract negotiations and/or ulitimate competition.!!

Everyone have a great week-end, enjoy your banter very much Peter.!! keep it up

KEIKO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext